Dr. Anil Joy
Claim this profileUniversity of Alberta / Cross Cancer Institute
Studies Breast Cancer
Studies Lung Cancer
2 reported clinical trials
7 drugs studied
Area of expertise
1Breast Cancer
Stage IV
Stage III
HER2 positive
2Lung Cancer
Stage IV
PD-L1 positive
Stage III
Affiliated Hospitals
More about Anil Joy
Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Anil Joy has experience with
- Pertuzumab
- Placebo
- Trastuzumab
- Tucatinib
- Carboplatin
- Pembrolizumab
Breakdown of trials Anil Joy has run
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anil Joy specialize in?
Anil Joy focuses on Breast Cancer and Lung Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Anil Joy currently recruiting for clinical trials?
No, Anil Joy is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Anil Joy has studied deeply?
Yes, Anil Joy has studied treatments such as Pertuzumab, Placebo, Trastuzumab.
What is the best way to schedule an appointment with Anil Joy?
Apply for one of the trials that Anil Joy is conducting.
What is the office address of Anil Joy?
The office of Anil Joy is located at: University of Alberta / Cross Cancer Institute, Edmonton, Alberta T6G 1Z2 Canada. This is the address for their practice at the University of Alberta / Cross Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.